Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
12.76
-0.22 (-1.69%)
At close: Apr 1, 2025, 4:00 PM
11.86
-0.90 (-7.03%)
After-hours: Apr 1, 2025, 4:38 PM EDT
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eton Pharmaceuticals stock have an average target of 27.67, with a low estimate of 24 and a high estimate of 33. The average target predicts an increase of 116.85% from the current stock price of 12.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $23 → $26 | Strong Buy | Maintains | $23 → $26 | +103.76% | Mar 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $21 → $24 | Strong Buy | Reiterates | $21 → $24 | +88.09% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +158.62% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $33 | Strong Buy | Maintains | $17 → $33 | +158.62% | Jan 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +64.58% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
81.02M
from 39.01M
Increased by 107.69%
Revenue Next Year
134.09M
from 81.02M
Increased by 65.50%
EPS This Year
0.41
from -0.15
EPS Next Year
1.24
from 0.41
Increased by 204.17%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 107.8M | 199.2M | 138.5M | ||
| Avg | 81.0M | 134.1M | 134.5M | ||
| Low | 64.3M | 98.1M | 129.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 176.4% | 145.8% | 3.3% | ||
| Avg | 107.7% | 65.5% | 0.3% | ||
| Low | 64.8% | 21.1% | -3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.46 | 1.65 | 1.94 | ||
| Avg | 0.41 | 1.24 | 1.68 | ||
| Low | 0.33 | 0.98 | 1.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 304.0% | 56.5% | ||
| Avg | - | 204.2% | 35.6% | ||
| Low | - | 140.2% | 14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.